
20/06/2025
The Dog Aging Project, a long-term study of healthy aging in companion dogs led by Texas A&M, Tufts, and the University of Washington, currently has over 50,000 dogs enrolled in the observational study, but they want to continue to enroll more. Enrollment is easy, and participation is free. Enrolled dogs remain at home living their normal lives, while participants provide information through annual surveys and optional at-home activities. Participation helps researchers identify how to help dogs live healthier, longer lives.
In addition, they are actively recruiting older dogs to participate in the Test of Rapamycin in Aging Dogs (TRIAD), a clinical trial to evaluate if rapamycin has an effect on heart health, mobility, cognitive function, and lifespan in canines. For the clinical trial, dogs need to be at least 7 years old, between 44 pounds and 120 pounds, and healthy. Clinical trial sites are located throughout the U.S., including a new site in Cockeysville, MD, and Vienna, VA.
Enroll your dog in TRIAD, a clinical trial by Dog Aging Project to study Rapamycin's effects on health and aging. Join now!